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PCardiac Imaging
Prediction of Mortality and Major Cardiac
Events by Exercise Echocardiography in Patients
With Normal Exercise Electrocardiographic Testing
Alberto Bouzas-Mosquera, MD,* Jesús Peteiro, MD, PHD,* Nemesio Álvarez-Garcı´a, MD,*
Francisco J. Broullo´n, MS,† Victor X. Mosquera, MD,‡ Lourdes Garcı´a-Bueno, MD,*
Luis Ferro, MD,* Alfonso Castro-Beiras, MD, PHD*§
A Coruña, Spain
Objectives We sought to assess the value of exercise echocardiography (EE) for predicting outcome in patients with known
or suspected coronary artery disease and normal exercise electrocardiogram (ECG) testing.
Background The prognostic value of EE in patients with normal exercise ECG testing has not been characterized.
Methods We studied 4,004 consecutive patients (2,358 men, mean age [ SD] 59.6  12.5 years) with interpretable
ECG who underwent treadmill EE and did not develop chest pain or ischemic ECG abnormalities during the tests.
Wall motion score index (WMSI) was evaluated at rest and with exercise, and the difference (WMSI) was calcu-
lated. Ischemia was defined as the development of new or worsening wall motion abnormalities with exercise.
End points were all-cause mortality and major cardiac events (MACE).
Results Overall, 669 patients (16.7%) developed ischemia with exercise. During a mean follow-up of 4.5  3.4 years,
313 patients died, and 183 patients had a MACE before any revascularization procedure. The 5-year mortality
and MACE rates were 6.4% and 4.2% in patients without ischemia versus 12.1% and 10.1% in those with isch-
emia, respectively (p  0.001). In the multivariate analysis, WMSI remained an independent predictor of mor-
tality (hazard ratio [HR]: 2.73, 95% confidence interval [CI]: 1.40 to 5.32, p  0.003) and MACE (HR: 3.59, 95%
CI: 1.42 to 9.07, p  0.007). The addition of the EE results to the clinical, resting echocardiographic and exer-
cise hemodynamic data significantly increased the global chi-square of the models for the prediction of mortality
(p  0.005) and MACE (p  0.009).
Conclusions The use of EE provides significant prognostic information for predicting mortality and MACE in patients with in-
terpretable ECG and normal exercise ECG testing. (J Am Coll Cardiol 2009;53:1981–90) © 2009 by the
American College of Cardiology Foundation











ihe American Heart Association/American College of
ardiology practice guidelines (1,2) recommend exercise
lectrocardiogram (ECG) testing as the preferred initial
oninvasive test for the diagnosis and risk stratification of
atients with suspected coronary artery disease (CAD) and
nterpretable resting ECG in the absence of treatment with
igoxin.
Exercise echocardiography (EE) is another established
echnique for the diagnosis and risk stratification of patients
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adrid, Spain. Part of this study was presented during the Young Investigators’
ward Session at the European Society of Cardiology Congress 2008, Munich,
ermany, September 2008.v
Manuscript received October 23, 2008; revised manuscript received January 6,
009, accepted January 19, 2009.ith known or suspected CAD (3–10). It is well known that
xercise-induced wall motion abnormalities (WMA) appear
arlier in the ischemic cascade than angina or ST-segment
hanges, which are the end points of treadmill exercise
CG testing. On the other hand, EE may provide compa-
able information with nuclear imaging techniques at a
ignificantly lower cost (11).
See page 1991
Patients with suspected CAD who do not develop chest
ain or ischemic ECG abnormalities during exercise ECG
esting may be deemed to be at low risk of cardiac events,
ut the lower sensitivity of this test for the detection of
bstructive CAD may potentially translate into failure to
dentify some patients at risk. However, the prognostic
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Thus, the purpose of this study
was to assess the value of EE for
predicting long-term mortality
and cardiac events in patients with
interpretable ECG and normal ex-
ercise ECG testing.
Methods
Patients. Between March 1,
1995, and December 31, 2007,
5,740 patients with known or
suspected CAD and interpret-
able resting ECG underwent EE
t our institution. Of them, 1,736 patients (30.2%) devel-
ped chest pain and/or ischemic ECG abnormalities during
he tests and were excluded; thus, 4,004 patients without
ny clinical or electrocardiographic evidence of myocardial
schemia during the tests were finally included in the study.
ll patients gave informed consent before testing, and the
tudy was approved by the local research ethics committee.
Demographic and clinical data, as well as stress testing
esults, were entered in our prospective database at the time
f the procedures. Patients referred for evaluation of chest
ain were classified as having typical angina, probable
ngina, or nonischemic chest pain as previously described
12). A history of CAD was defined as previous myocardial
nfarction, previous coronary revascularization, or previous
Baseline Characteristics of 4,004 Patients WithInterpretable ECG and Normal Exercise ECG Tes
Table 1 Baseline Characteristics of 4,004 PInterpretable ECG and Normal Exerc
All Patients
(n  4,004)
Male sex 2,358 (58.9)
Age (yrs) 59.6 12.5




History of coronary artery disease 1,153 (28.8)
Prior myocardial infarction 871 (21.8)
30 days before EE 368 (9.2)
30 days before EE 519 (13.0)
Prior coronary revascularization 611 (15.3)
PCI 465 (11.6)
CABG 158 (3.9)
Chest pain 2,779 (69.4)
Typical angina 151 (3.8)
Atypical/probable angina 1,748 (43.7)
Nonanginal chest pain 880 (22.0)
Atrial fibrillation 72 (1.8)
Antianginal drugs
Beta-blockers 235 (5.9)









MACE  major adverse
cardiac event(s)
WMA  wall motion
abnormalities
WMSI  wall motion score
indexValues are n (%) or mean  SD.
CABG  coronary artery bypass grafting; EE  exercise echocardiography;ngiographic documentation of any significant (50%)
oronary stenosis. In the subgroup of patients without a
istory of CAD, the pre-test probability of CAD was
ssessed according to a previously validated score (13). The
esting ECG was considered interpretable in the absence of
eft bundle branch block, pre-excitation, paced rhythm, left
entricular hypertrophy, repolarization abnormalities, or
reatment with digoxin.
Whenever possible, beta-blocker therapy was discontin-
ed at least 48 h before testing. However, 5.9% of the
atients were under the influence of beta-blocker drugs at
he time of their tests.
xercise treadmill testing. Heart rate, blood pressure, and
12-lead ECG were obtained at baseline and at each stage
f the exercise protocol. Patients were encouraged to per-
orm a treadmill exercise test (Bruce protocol 86.5%, mod-
fied Bruce 4.4%, modified Bruce for sportive people 7.9%,
aughton 1.2%) until they reached an end point. Exercise
nd points included physical exhaustion, significant arrhyth-
ia, severe hypertension (systolic blood pressure 240 mm
g or diastolic blood pressure 110 mm Hg), or severe
ypotensive response (decrease 20 mm Hg in systolic
lood pressure from baseline). Ischemic ECG abnormalities
uring the test were defined as the development of ST-
egment deviation of 1 mm 80 ms after the J point; as
ndicated previously, these patients were excluded from the







(n  669) p Value
1,855 (55.6) 503 (75.2) 0.001
59.0 12.7 62.8 11.1 0.001
880 (26.4) 230 (34.4) 0.001
481 (14.4) 139 (20.8) 0.001
1,621 (48.6) 336 (50.2) 0.45
1,511 (45.3) 297 (44.4) 0.67
777 (23.3) 376 (56.2) 0.001
559 (16.8) 312 (46.6) 0.001
224 (6.7) 144 (21.5) 0.001
341 (10.2) 178 (26.6) 0.001
432 (13.0) 179 (26.8) 0.001
321 (9.6) 144 (21.5) 0.001
119 (3.6) 39 (5.8) 0.006
2,406 (72.1) 373 (55.8) 0.001
108 (3.2) 43 (6.4) 0.001
1,465 (43.9) 283 (42.3) 0.44
833 (25.0) 47 (7.0) 0.001
62 (1.9) 10 (1.5) 0.52
186 (5.6) 49 (7.3) 0.08
404 (12.1) 93 (13.8) 0.20
808 (24.2) 201 (30.0) 0.002ting
atien
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May 26, 2009:1981–90 Exercise Echocardiography in Normal Exercise ECG TestingE. Echocardiographic imaging was performed from the
pical long-axis, apical 4- and 2-chamber, and parasternal
ong- and short-axis views, at rest, at peak exercise (16,17),
nd immediately after exercise. Peak imaging was per-
ormed with the patient still exercising, when signs of
xhaustion were present or an end point was achieved. The
atient was asked to walk quickly rather than run, to
ecrease body and respiratory movements. The transducer
as firmly positioned on the apical and parasternal area by
pplying slight pressure to the patient’s back with the left
and, so maintaining the patient between the transducer
nd the left hand, to avoid movement. Peak and post-
xercise images were obtained with continuous imaging
Figure 1 Outcome of Patients According to Exercise Echocardi
(A) All-cause mortality and (B) major cardiac event curves in patients with versus
Exercise Echocardiographic Data of the 4,004 P
Table 2 Exercise Echocardiographic Data of
All
(n






Rate-pressure product,  103 mm Hg beats/min
Rest 10.5
Peak 25.9
Submaximal test, n (%) 78
Metabolic equivalents 9
Left ventricular ejection fraction, %
Rest 59
Peak 66
Resting wall motion abnormalities, n (%) 71
Wall motion score index
Rest 1.0
Peak 1.1apture. Image acquisition was performed online and stored
n an optical disk. The images corresponding to each view
aving the best quality at peak and post-exercise were
hosen for comparison with rest images.
Echocardiographic analysis was performed on a digital
uad-screen display system. Regional wall motion was
valuated with a 16-segment model of the left ventricle (18).
ach segment was graded on a 4-point scale, with normal
all motion scoring 1, hypokinetic 2, akinetic 3, and
yskinetic  4. Wall motion score index (WMSI) was
alculated at rest and at peak exercise as the sum of the scores
ivided by the number of segments. The change in WMSI
rom rest to peak exercise (WMSI) also was calculated.
hy Results








(n  669) p Value
9 134 19 135 19 0.14
9 173 30 171 29 0.09
5 79 15 77 14 0.001
1 150 21 145 19 0.001
.55 10.59 2.56 10.35 2.44 0.02
.93 26.09 5.96 25.01 5.70 0.001
5) 630 (18.9) 152 (22.7) 0.02
.2 9.8 3.1 9.4 3.3 0.01
.9 60.3 6.6 56.6 7.3 0.001
.9 68.5 8.4 56.3 10.8 0.001
9) 430 (12.1) 285 (42.3) 0.001
.19 1.05 0.18 1.15 0.24 0.001
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Exercise Echocardiography in Normal Exercise ECG Testing May 26, 2009:1981–90Ischemia was defined as the development of new or
orsening WMA with exercise, except worsening from
kinesia to dyskinesia, which was not considered an isch-
mic response, and isolated hypokinesia of the inferobasal
egment, which was not considered abnormal (19). Exten-
ive ischemia was defined as the development of new or
orsening WMA involving at least 3 myocardial segments.
ultivessel ischemia was defined as ischemia involving at
east 2 different coronary territories.
Patients with poor imaging quality were not excluded,
nd contrast was exceptionally administered (n  7). The
ercentage of patients in whom 15 segments could be
ssessed was 3% at rest and 5.1% during and/or immediately
fter exercise. The feasibility and accuracy of peak versus
mmediate post-exercise imaging during treadmill EE have
Figure 2 Outcome of Patients Stratified by Sex and Diabetes
(A) Mortality and (B) major cardiac event curves in patients with versus without is
on exercise echocardiography stratified according to sex and diabetes. Continuedeen reported previously (16,17). mollow-up and end points. Follow-up was obtained by
eview of hospital databases, medical records, and death
ertificates, as well as by telephone interviews when neces-
ary. End points were all-cause mortality and major adverse
ardiac events (MACE) (i.e., cardiac death and nonfatal
yocardial infarction). Cardiac death was defined as death
ue to acute myocardial infarction, congestive heart failure,
ife-threatening arrhythmias, or cardiac arrest; unexpected,
therwise-unexplained sudden death also was considered
ardiac death. Myocardial infarction was defined as the
ppearance of new symptoms of myocardial ischemia or
schemic ECG changes accompanied by increases in mark-
rs of myocardial necrosis. Revascularization procedures
uring follow-up were collected although they were not
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May 26, 2009:1981–90 Exercise Echocardiography in Normal Exercise ECG Testingtatistical analysis. Categorical variables were reported as
ercentages and comparison between groups based on the
hi-square test. Continuous variables were reported as
ean  SD, and differences were assessed with the un-
aired t test or Mann-Whitney U test as appropriate.
Cumulative event curves were estimated by the Kaplan-
eier method and compared by the log-rank test. Patients
ere censored at the time of a coronary revascularization
rocedure or noncardiac death for the MACE analysis, but
ot for the mortality analysis (20).
Univariable and multivariable associations of clinical,
xercise, and EE variables with the end points were assessed
ith Cox’s proportional hazards models. Variables were
elected in a stepwise forward selection manner, with entry
nd retention set at a significance level of 0.05. Hazard
atios with 95% confidence intervals were estimated.
The incremental value of EE results over clinical, resting
chocardiographic, and exercise treadmill testing variables
Figure 2 Continuedas assessed in 4 modeling steps in the same order as in Tlinical practice. The first step was based on clinical data.
esting echocardiographic data were then added in the
ollowing step. The third step consisted of hemodynamic
ata obtained during exercise. In the final step the EE data
ere added. The chi-square value of each model and the
ncremental value of adding the different variables were
stimated. A statistically significant increase in the global
hi-square of the model defined incremental prognostic
alue (21). Statistical analyses were performed with the use
f SPSS software (version 15.0, SPSS, Chicago, Illinois).
esults
aseline and EE. Mean age was 59.6  12.5 years, and
,358 patients (58.9%) were men. Clinical and demographic
haracteristics of the 4,004 patients are summarized in
able 1.
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Exercise Echocardiography in Normal Exercise ECG Testing May 26, 2009:1981–90atients (87.4%). Overall, 715 patients (17.9%) had resting
MA and 669 (16.7%) developed ischemia with exercise;
f them, 438 patients (10.9%) had extensive ischemia and
19 patients (5.5%) developed multivessel ischemia.
Patients with ischemia were older, were more likely to be
ale or to have a history of myocardial infarction or
oronary revascularization, and presented more frequently
ith typical chest pain (Table 1); these patients also had
ower workload and lower peak rate-pressure product than
atients without ischemia (Table 2). The majority of pa-
ients had no previous history of CAD (n  2,851, 71.2%).
n this subgroup, 142 patients (5.0%) had resting WMA
nd 293 patients (10.3%) developed ischemia with exercise.
utcomes. During a mean follow-up of 4.5  3.4 years,
13 deaths occurred. Five-year mortality rate was 6.4% in
he group of patients without ischemia versus 12.1% in the
roup with ischemia (p  0.001) (Fig. 1A). Overall, 380
atients underwent revascularization procedures during
ollow-up (percutaneous coronary intervention in 313
7.8%] patients and coronary artery bypass grafting in 67
1.7%] patients). A total of 183 patients experienced a
ACE before any revascularization procedure, including 63
ardiac deaths and 120 nonfatal myocardial infarctions. Five-
ear MACE rate was 4.2% in the nonischemic group versus
0.1% in the ischemic group (p  0.001) (Fig. 1B). Patients
ith extensive ischemia or multivessel ischemia were at greater
isk of events (5-year mortality rate of 13.3% and 15.9%, and
-year MACE rate of 12.1% and 16.2%, respectively).
The association of ischemia during EE with events
emained significant in the subgroup of patients without a
istory of myocardial infarction (5-year mortality rate 12.9%
n patients with ischemia vs. 6.1% in patients without
schemia, p 0.001, and 5-year MACE rate 8.8% vs. 3.3%,
 0.001), in those without a history of coronary revascu-
arization (5-year mortality rate 12.5% vs. 6.3%, p  0.001,
nd 5-year MACE rate 9.4% vs. 3.7%, p  0.001), and in
hose without any history of CAD (5-year mortality rate
3.3% vs. 5.7%, p 0.001, and 5-year MACE rate 7.8% vs.
.7%, p  0.001). Patients with a low-risk Duke score who
eveloped ischemia on EE also had a greater 5-year mor-
ality rate (9.5% vs. 4.5%, p  0.001) and 5-year MACE
ate (12.7% vs 2.7%, p  0.001) as compared with patients
ithout ischemia. Figure 2 shows mortality and MACE
urves stratified according to sex and diabetes.
The subgroup of patients without a history of CAD was
urther stratified according to their pre-test probability of
AD (low pre-test probability: n  492 patients; interme-
iate pre-test probability: n  1,873 patients; high pre-test
robability: n  486 patients). As shown in Figure 3,
ACE rate was consistently and significantly greater in
atients with ischemia as compared with those without
schemia in all subgroups according to their pre-test likeli-
ood of CAD. The association of ischemia with mortality
as highly significant in the subgroup of patients with
ntermediate pre-test probability of CAD (5-year mortality
ate 13.4% in patients with ischemia vs. 6.1% in patients dithout ischemia, p  0.001). Although there was a trend
oward a greater mortality rate in the subgroups of patients
ith low and high pre-test probability of CAD who
eveloped ischemia as compared with those who did not
5-year mortality rate 7.1% vs. 1.9% for patients with low
re-test probability of CAD and 11.8% vs. 6.1% for patients
ith high pre-test probability of CAD, respectively), these
ifferences did not reach statistical significance.
On the other hand, patients with a history of CAD who
eveloped ischemia had a nonsignificant trend toward
reater mortality and MACE rates as compared with those
ithout ischemia (5-year mortality rate 11.4% vs. 8.4% and
-year MACE rate 11.7% vs. 8.8%, respectively, p  0.05
or both comparisons).
The presence of WMA at rest was also associated with a
ignificantly worse outcome (Fig. 4). Patients with both
esting WMA and ischemia had a greater 5-year mortality
ate (16.3%) and 5-year MACE rate (13.2%). On the
ontrary, patients with neither resting WMA nor ischemia
ere at lower risk of events (5-year mortality rate 5.9% and
-year MACE rate 3.2%). In the subgroup of patients
ithout a history of CAD, the presence of resting WMA
lso identified a subset of patients with worse outcome
5-year mortality rate 19.5% vs. 5.7%, p 0.001, and 5-year
ACE rate 12.7% vs. 2.7%, p  0.001).
redictors of outcome and incremental value of EE.
nivariate associations with mortality and MACE are listed
n Table 3. In multivariate analysis, resting WMSI and
WMSI remained independent predictors of both total
ortality and MACE (Tables 4 and 5).
The global chi-square of the clinical model for predicting
ll-cause mortality was 170 (p  0.001); the addition of
esting echocardiographic data (resting WMSI) increased
he global chi-square to 231 (p  0.001); the inclusion of
emodynamic variables during exercise added significantly
o the model (chi-square test  398, p  0.001); the
ubsequent addition of the EE results (WMSI) to the
linical, resting echocardiographic, and treadmill exercise
ata also provided incremental information for predicting
ortality (chi-square test  408, p  0.005).
The global chi-square of the clinical model for predicting
ACE was 83 (p  0.001); after adding the resting
MSI, the global chi-square increased to 128 (p  0.001);
readmill exercise data also added significantly to the model
chi-square test 150, p 0.001); finally, the addition of the
E results increased the global chi-square to 161 (p 0.009).
iscussion
o the best of our knowledge, the present study is the first
o assess the prognostic implications of EE in a large cohort
f patients with interpretable ECG and normal exercise
CG testing. This study shows that a significant proportion
f patients with known or suspected CAD and normal
xercise ECG testing develop new or worsening WMA
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May 26, 2009:1981–90 Exercise Echocardiography in Normal Exercise ECG Testingic information for the prediction of mortality and cardiac
vents in these patients.
Our results reflect the limitations of the negative predic-
ive value of exercise ECG testing as compared with EE. In
ur study, 1 of 6 patients without chest pain or ischemic
CG abnormalities during the stress test developed new or
orsening WMA. Furthermore, 2 of 3 patients with isch-
mia had extensive ischemia, and 1 of 3 had multivessel
nvolvement.
The superior diagnostic accuracy of EE translates into
etter risk stratification. Although patients who do not
evelop chest pain or ischemic ECG abnormalities during
xercise treadmill testing have an overall low risk of events,
ith the use of EE, we are able to identify a subset of
atients at greater risk. In fact, the annualized mortality and
ACE rates were 2% in the subgroup of patients with
Figure 3 Major Cardiac Event Curves Stratified by the Pre-Test
Major cardiac event curves in patients without a history of coronary artery disease
according to the pre-test probability of CAD and the development of ischemia on eschemia detected by EE; moreover, the mortality rate was olmost twice as high as in the subgroup without ischemia,
nd the MACE rate was 2.4 times higher. On the contrary,
normal EE portends a good prognosis. The annualized
ate of major cardiac events was 0.84% in patients without
schemia, and 0.64% in those with normal EE as defined by
he American Society of Echocardiography (3) (i.e., normal
eft ventricular wall motion at rest and with exercise).
hese results are similar to those reported in a recent
eta-analysis (22).
The prognostic value of EE has been previously well
stablished (4–10). In particular, the value of ischemia on
E for predicting long-term mortality was evaluated by
arwick et al. (5) in a large cohort of patients with known
r suspected CAD. These authors found that ischemia
dded incremental value to the results of exercise ECG
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Exercise Echocardiography in Normal Exercise ECG Testing May 26, 2009:1981–90iate risk by the Duke score. Notably, although most
atients in our study were at low risk according to the Duke
core, ischemia was still strongly associated with worse
utcome. Furthermore, the greatest differences in mortality
nd MACE rates in our study were found in the subgroup
Figure 4 Outcome of Patients According to the Presence of Re
(A) Mortality and (B) major cardiac event curves stratified according to the presen
Univariate Predictors of Mortality and Major Ca
Table 3 Univariate Predictors of Mortality a
All-Cau
HR (95% CI
Male sex 1.78 (1.39–2.2
Age 1.07 (1.06–1.0




Previous myocardial infarction 1.40 (1.10–1.7
Previous coronary revascularization 1.20 (0.89–1.6
Typical chest pain 1.42 (0.84–2.3
Atrial fibrillation 2.74 (1.22–6.1
Beta-blockers 1.10 (0.72–1.6
Calcium-channel blockers 1.81 (1.40–2.3
Nitrates 2.04 (1.63–2.5
Peak RPP (per 103 U) 0.91 (0.89–0.9
Sub-maximal test 2.02 (1.60–2.5
Metabolic equivalents 0.77 (0.74–0.8
Resting LVEF 0.95 (0.94–0.9
Peak LVEF 0.96 (0.95–0.9
Resting WMSI 5.23 (3.70–7.3
Peak WMSI 5.31 (3.88–7.2
WMSI 5.34 (2.75–10.
Resting WMA 1.97 (1.56–2.4
Ischemia 1.84 (1.43–2.3CI  confidence interval; HR  hazard ratio; LVEF  left ventricular eje
abnormalities; WMSI  wall motion score index.f patients without a history of CAD, which represents
ore than 70% of the population. The value of treadmill
E over the Duke score for the prediction of cardiac events
n patients with interpretable ECG was also reported in a
revious study by our group (10). However, patients who
or Exercise Wall Motion Abnormalities
bsence of resting wall motion abnormalities (RWMA) and/or ischemia.
Events
ajor Cardiac Events
rtality Major Cardiac Events
p Value HR (95% CI) p Value
0.001 2.32 (1.66–3.23) 0.001
0.001 1.02 (1.00–1.03) 0.02
0.10 1.57 (1.14–2.17) 0.006
0.001 1.85 (1.31–2.63) 0.001
0.03 1.26 (0.94–1.69) 0.13
0.19 0.96 (0.71–1.30) 0.80
0.006 2.78 (2.07–3.72) 0.001
0.24 1.80 (1.26–2.55) 0.001
0.19 1.62 (0.83–3.16) 0.16
0.015 1.38 (0.34–5.59) 0.65
0.67 1.88 (1.18–3.00) 0.008
0.001 1.85 (1.31–2.61) 0.001
0.001 1.91 (1.41–2.57) 0.001
0.001 0.94 (0.92–0.97) 0.001
0.001 2.03 (1.49–2.76) 0.001
0.001 0.90 (0.86–0.95) 0.001
0.001 0.95 (0.93–0.96) 0.001
0.001 0.96 (0.95–0.97) 0.001
0.001 6.76 (4.42–10.35) 0.001
0.001 6.97 (4.71–10.31) 0.001
0.001 7.41 (3.00–18.33) 0.001
0.001 3.24 (2.42–4.35) 0.001
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May 26, 2009:1981–90 Exercise Echocardiography in Normal Exercise ECG Testingid not develop chest pain or ischemic ECG abnormalities
uring their tests were not specifically evaluated.
Current American Heart Association/American College
f Cardiology practice guidelines (1,2,23) recommend ex-
rcise ECG testing as the preferred initial noninvasive test
or the diagnosis and risk stratification of patients with
ormal resting ECG and suspected CAD in the absence of
reatment with digoxin. The main argument against the
outine performance of stress imaging procedures in patients
ith interpretable ECG is a higher cost and lower yield of
uch strategy (24,25). However, EE has lower cost than
ther noninvasive imaging techniques, and it is not clear
hether the lower initial cost of exercise ECG testing
ranslates into a lower overall cost of patient care. In this
espect, some authors (26–28) have suggested that EE is a
ost-effective technique, especially in populations in which
xercise ECG testing has a high rate of false-positive results
3); in these patients, the greater specificity of EE may avoid
he use of additional unnecessary diagnostic procedures. In
ddition, the prognostic implications of the greater negative
redictive value of EE are also to be taken into account.
lthough we did not evaluate the cost-effectiveness of a
trategy based on EE in the population included in our
tudy, patients with abnormal results on EE might be
isdiagnosed or stratified incorrectly on the basis of exercise
CG testing results, which might potentially preclude an
ppropriate management. Furthermore, the European So-
iety of Cardiology (29) recommends the use of exercise
tress with imaging techniques as an alternative to exercise
CG where facilities, costs, and personnel resources allow
Class IIa, Level of Evidence: B). However, it should be
ecognized that the relative yield of noninvasive imaging
echniques in terms of avoiding false-negative results may be
uestionable in patients with low pre-test probability of
AD (30), in whom exercise ECG testing may maintain an
cceptably high negative predictive value.
tudy limitations. First, this was an observational study
nd, hence, unmeasured confounding may account for at
east part of the observed differences in outcomes. Given
hat the results of the tests were available to treating
hysicians, patients with ischemic results on EE may have
een more likely to receive medical therapy and to undergo
oronary revascularization procedures; thus, the actual prog-
ostic value of EE may have been significantly underesti-
ultivariate Predictors of All-Cause Mortality
Table 4 Multivariate Predictors of All-Cause Mortality
HR (95% CI) p Value
Male sex 2.45 (1.89–3.17) 0.001
Age 1.04 (1.02–1.05) 0.001
Calcium-channel blockers 1.42 (1.09–1.85) 0.009
Peak RPP (per 103 U) 0.97 (0.96–0.99) 0.016
Metabolic equivalents 0.81 (0.78–0.84) 0.001
Resting WMSI 2.22 (1.52–3.25) 0.001
WMSI 2.73 (1.40–5.32) 0.003bbreviations as in Table 3.ated, particularly in patients with extensive ischemia. In
ddition, the medication change after testing and its effect
n outcome could not be assessed. On the other hand, the
scertainment of the cause of death may be susceptible to
ias and misclassification (31). Finally, we routinely perform
maging acquisition during peak exercise in addition to
ost-exercise imaging because it has shown higher sensitiv-
ty (16,17); therefore, our results could have been different if
e had used post-exercise imaging alone.
onclusions
not-inconsiderable proportion of patients with suspected
AD and normal resting ECG, who do not have chest pain
r ischemic ECG changes during treadmill stress testing,
evelop new or worsening WMA with exercise, and these
ata provide significant prognostic information for the
rediction of mortality and major cardiac events. Patients
ith abnormal results on EE, who might be misdiagnosed
r stratified incorrectly on the basis of exercise ECG testing
esults alone, might benefit from appropriate management.
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